Previous Article | Next Article ![]()
Infection and Immunity, February 2001, p. 832-837, Vol. 69, No. 2
Phagocyte Research Laboratory, Department of
Medical Microbiology and Immunology, University of Göteborg,
Göteborg,1 and Section MIG,
Institute of Laboratory Medicine, Lund University,
Lund,2 Sweden
Received 13 April 2000/Returned for modification 15 June
2000/Accepted 8 November 2000
We have earlier shown that galectin-3, a lactose-binding mammalian
lectin that is secreted from activated macrophages, basophils, and mast
cells, induces activation of the NADPH oxidase in exudated but not in
peripheral blood neutrophils (A. Karlsson, P. Follin, H. Leffler, and
C. Dahlgren, Blood 91:3430-3438, 1998). The alteration in
responsiveness occurring during extravasation correlated with mobilization of the gelatinase and/or specific granules to the cell
surface, indicating a role for mobilizable galectin-3 receptors. In
this study we have investigated galectin-3-induced NADPH oxidase activation, measured as superoxide production, in lipopolysaccharide (LPS)-primed neutrophils. Upon galectin-3 challenge, the LPS-primed cells produced superoxide, both extracellularly and intracellularly. A
primed extracellular response to formylmethionyl-Leu-Phe (fMLF) was
also achieved. The exposure of complement receptors 1 and 3 as well as
the formyl peptide receptor on the cell surface was markedly increased
after LPS treatment, indicating that granule fusion with the plasma
membrane had occurred. Further assessment of specific markers for
neutrophil granules showed that the LPS treatment had mobilized the
gelatinase granules but only a minor fraction of the specific granules.
We thus suggest that the mechanism behind LPS priming lies at the level
of granule (receptor) mobilization for galectin-3 as well as for fMLF.
The innate immune defense
toward microorganisms is largely dependent on neutrophil
granulocytes. The neutrophil effector functions include the production
of oxygen radicals that have bactericidal functions as well as being
potentially tissue destructive (3). Hence, tight
regulation of the radical-producing enzyme system, the NADPH oxidase,
is critical for mounting an effective defense against infection without
destroying surrounding tissues.
Most studies of neutrophil activation use cells isolated from
peripheral blood. However, neutrophils act in vivo mainly after exudation from the bloodstream. Concomitant with extravasation, the
cells become primed (i.e., hyperresponsive) with respect to the NADPH
oxidase activity induced by inflammatory mediators, e.g., the
chemoattractant formylmethionyl-Leu-Phe (fMLF) (17). Similarly, galectin-3, an endogenous, lactose-binding lectin, activates
the NADPH oxidase in exudated but not peripheral blood neutrophils
(22). In addition to having stimulating effects on immune
cells, galectin-3 is released in large amounts from activated
macrophages and mast cells (27, 28, 39), supporting its
participation in inflammatory processes, potentially as an inflammatory
mediator. For a review on galectin-3 and its biological functions, see
reference 26.
The priming phenomenon has been described for many settings in
neutrophil activation processes, prominent examples being the effect of
bacterial lipopolysaccharide (LPS) and the adhesion-related priming of
tumor necrosis factor-induced responses (35). Many priming
mechanisms have been suggested, and it is reasonable to believe that
different mechanisms, alone or in combination, may be the cause of
different priming events (9, 14, 20). Neutrophils having
encountered bacterial LPS are primed with respect to oxidative response; i.e., LPS per se does not activate the NADPH oxidase but
induces hyperresponsiveness to other stimuli, such as fMLF (13,
19, 43, 45). The prevailing views propose that the mechanism for
this LPS priming involves alterations of intracellular signaling (e.g.,
changed levels of various second messengers) and/or direct effects on
the NADPH oxidase (19). We have recently proposed that one
important mechanism behind the primed state induced during neutrophil
extravasation is the mobilization of intracellular granules, endowing
the plasma membrane with granule membrane proteins (22).
Such mobilization of specific receptors could explain priming
vis-à-vis fMLF and galectin-3, respectively.
To shed further light on this issue with regard to LPS priming, we have
investigated the effect of LPS on the neutrophil response to galectin-3
and the concomitant mobilization of granules. The data suggest that LPS
priming is sufficient to induce galectin-3 responsiveness and that
gelatinase granule mobilization (accompanied by receptor upregulation)
is a major cause for the galectin-3 responding state. We also show that
receptor mobilization is a plausible explanation for the LPS-induced
priming of the neutrophil response to fMLF.
Isolation of human neutrophils.
Neutrophils were isolated
from buffy coats from healthy blood donors by using dextran
sedimentation and Ficoll-Paque gradient centrifugation
(8). The cells were washed and resuspended
(107/ml) in Krebs-Ringer phosphate buffer containing
glucose (10 mM), Ca2+ (1 mM), and Mg2+ (1.5 mM)
(KRG; pH 7.3). This procedure allows for cells to be isolated with
minimal mobilization effects (1).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.832-837.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Lipopolysaccharide-Induced Gelatinase Granule
Mobilization Primes Neutrophils for Activation by Galectin-3 and
Formylmethionyl-Leu-Phe
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Priming with LPS. LPS from Escherichia coli serotype O111:B4 was dissolved in KRG to 1 mg/ml and sonicated to prepare a homogeneous solution. Cells (107/ml) were incubated in the presence or absence of LPS (10 µg/ml [a relatively high concentration required to induce priming in the absence of serum]) at 4 or 37°C for 30 min and were then directly used for NADPH oxidase activation studies or marker analysis.
Preparation of galectin-3. Recombinant human galectin-3 was produced in E. coli and purified as previously described (31). The lectin was stored at 4°C in phosphate-buffered saline (pH 7.2) containing lactose (150 mM). When used, the lectin preparation was applied to a gel filtration column (PD10; Pharmacia, Uppsala, Sweden) in order to remove lactose and was diluted to 400 µg/ml in KRG.
Neutrophil NADPH oxidase activity.
Superoxide anion
production by the NADPH oxidase was determined using a
luminol/isoluminol enhanced chemiluminescence (CL) system
(12). CL activity was measured in a six-channel Biolumat LB 9505 (Berthold Co., Wildbad, Germany), using disposable 4-ml polypropylene tubes with a 0.90-ml reaction mixture containing 106 neutrophils. The tubes were equilibrated in the
Biolumat for 5 min at 37°C, after which the stimulus (0.1 ml) was
added. The light emission was recorded continuously. To quantify
intracellularly and extracellularly generated superoxide, two different
reaction mixtures were used. Tubes used for measurement of
extracellular release of superoxide anion contained neutrophils,
horseradish peroxidase (HRP; a cell-impermeable peroxidase; 4 U), and
isoluminol (a cell-impermeable CL substrate; 6 × 10
5 M) (30). By a direct comparison of the
superoxide dismutase (SOD)-inhibitable reduction of cytochrome
c and SOD-inhibitable CL, 7.2 × 107 cpm
was found to correspond to a production of 1 nmol of superoxide (a
millimolar extinction coefficient for cytochrome c of 21.1 was used). Tubes used for measurement of intracellular generation of
reactive oxygen species contained neutrophils, SOD (a cell-impermeable scavenger for O2
; 50 U), catalase (a
cell-impermeable scavenger for H2O2; 2,000 U)
and luminol (a cell-permeable CL substrate; 6 × 10
5
M). Results are presented as means and standard deviations (SD).
Marker analysis. The mobilization of subcellular organelles was determined by measuring the exposure of complement receptors 1 and 3 (CR1 and CR3, respectively) and the formyl peptide receptor (FPR) on the neutrophil surface as well as determining the release of gelatinase and vitamin B12-binding protein into the supernatant.
Exposure of CR1 was measured by labeling the cells with mouse anti-human CD35 (Dakopatts M0710; 10 µl to a cell pellet of 106 cells) and subsequent binding of fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin (DAKO F0479; 1/2,000). To measure CR3 exposure, the cells were labeled with phycoerythrin-conjugated monoclonal antibodies specific for CD11b (DAKO M741; 10 µl to a cell pellet of 106 cells). The cells were examined by FACScan (Becton Dickinson, Mountain View, Calif.) (29). The amount of FPR on the cell surface was determined by incubating the neutrophils with radiolabeled fMLF in the presence or absence of excess unlabeled fMLF as described earlier (1). In short, 100 µl of dibutylphthalate mixed with dinonylphthalate (10:3, vol/vol) was layered on top of 10 µl of urea (6 M) in Eppendorf tubes; 50 µl of [3H]fMLF (8 × 10
8 M) together with
50 µl of KRG or unlabeled fMLF (4 × 10
5 M) in KRG
was layered on top of the oil. Neutrophils (2 × 106;
100 µl) were added to the fMLF solution, and the tubes were incubated
on melting ice for 1 h. The tubes were centrifuged at 9,000 × g for 15 s in a Beckman microcentrifuge
(Beckman Instruments, Fullerton, Calif.) to remove unbound peptide. The
bottom of the centrifuge tubes (containing the pelleted cells) was
excised and collected for determination of cell-bound radioactivity.
The background (the measured value in the presence of excess unlabeled
fMLF) was subtracted from all values.
Vitamin B12-binding protein was determined with the
cyanocobalamin technique as described by Gottlieb et al.
(18). Gelatinase was measured using an enzyme-linked
immunosorbent assay (ELISA) (24).
Reagents. LPS (E. coli serotype O111:B4; L-2630), fMLF, phorbol myristate acetate (PMA), isoluminol, and luminol were obtained from Sigma Chemical Co. (St. Louis, Mo.). [3H]fMLF was supplied by Du Pont NEN (Boston, Mass.). Dibutylphthalate and dinonylphthalate was obtained from Merck (Whitehouse Station, N.J.). Catalase, SOD, and HRP were purchased from Boehringer (Mannheim, Germany). Dextran and Ficoll-Paque were from Pharmacia. [57Co]vitamin B12 was supplied by Amersham Laboratories (Amersham, Buckinghamshire, England). Antibodies for the gelatinase ELISA were a kind gift from Lars Kjeldsen and Niels Borregaard, Copenhagen, Denmark. All other antibodies were from DAKO (Glostrup, Denmark).
| |
RESULTS |
|---|
|
|
|---|
LPS-induced priming of neutrophil NADPH oxidase activity.
Neutrophil priming induced by bacterial LPS is a time- and
temperature-dependent phenomenon. To establish a reference for comparison with the literature (13, 19, 43, 45), we first measured fMLF-induced extracellular release of oxygen radicals from
LPS-primed and unprimed neutrophils (Fig.
1). In agreement with previous studies,
the response to fMLF was slightly increased in the cell population
incubated at 37°C in the absence of LPS (1), while
pretreatment of the cells with LPS for 30 min at 37°C showed a
markedly enhanced response to fMLF (10
7 M) (Fig. 1)
(13, 19). No increase in response was detected in cells
incubated with LPS at 4°C. There was no difference in superoxide
production between LPS-primed and nonprimed neutrophils stimulated with
the protein kinase C activator PMA (data not shown).
|
|
|
NADPH oxidase activity in enucleated neutrophil cytoplasts.
Cytoplasts, consisting of an organelle-free cytoplasm surrounded by
plasma membrane, have successfully been used to assess the role of
neutrophil granules in specific cellular responses (11,
15). We found that galectin-3 activated the NADPH oxidase in
nonprimed neutrophil cytoplasts, with a similar time course and about
30% magnitude (Fig. 4) of an equivalent
number of primed neutrophils (Fig. 2). The NADPH oxidase activity was
not further increased in cytoplasts pretreated with LPS (the ratio
between the CL activity in LPS-treated and nontreated cytoplasts being 0.95 ± 0.21 [n = 3]). Likewise, LPS failed to
prime cytoplasts when they were stimulated by fMLF (data not shown).
|
LPS-induced mobilization of subcellular organelles.
Receptors
for galectin-3 are stored in the gelatinase and specific granules in
peripheral blood neutrophils (16). We have suggested that
mobilization of these receptors to the cell surface is what renders the
cells responsive to galectin-3 after in vitro priming with fMLF or in
vivo extravasation (22). Similarly, the FPR mediating the
neutrophil response induced by fMLF is distributed among the plasma
membrane, the secretory vesicles, and the gelatinase and specific
granules (40). To assess the possibility that granule mobilization and increased receptor expression on the cell surface is
the cause of the priming effect induced by LPS, we examined the cell
surface exposure of known membrane components (Fig.
5) and extracellular release of granule
contents (Fig. 6) in the various cell
populations described above.
|
|
percent release of vitamin B12-binding
protein). With this calculation, about 60% of gelatinase granules were
mobilized in the presence of LPS, whereas about 20% were mobilized at
37°C without LPS.
| |
DISCUSSION |
|---|
|
|
|---|
We show that galectin-3 is a potent agonist of LPS-primed neutrophils but not of unprimed peripheral blood cells and that degranulation of gelatinase granules is a major event induced by LPS in neutrophils. These results raise two questions. The first, how do the data relate to previously proposed mechanisms for neutrophil priming by LPS and other agents, we have begun to address. The second, what role does galectin-3 play in relation to the pathophysiological effects of LPS, is a question that at the present we can only speculate upon.
The major degranulation effect specifically related to LPS is, interestingly, mobilization of gelatinase granules with little mobilization of specific granules. As noted in Results, about 60% of the gelatinase granules but only 5% of the specific granules were mobilized in the cells treated with LPS at 37°C. Mere incubation of the cells at 37°C resulted in 20% mobilization of gelatinase granules but contributed 3% of the 5% of mobilized specific granules. The specific signaling inducing this exclusive degranulation of the gelatinase granules will be further investigated.
The molecular mechanisms behind LPS-dependent priming of the response to fMLF, the most widely studied agonist in this context, have been extensively discussed. The suggested mechanisms include alterations of intracellular signaling pathways (increased protein phosphorylation, phospholipase activity, intracellular Ca2+ changes, and cross talk between Ca2+ increase and tyrosine phosphorylation), altered assembly of the NADPH oxidase, and proteolytic processing of cell surface proteins (13, 19, 20, 43, 44, 47). In addition, there are studies reporting an increased amount of FPR on LPS-primed neutrophils (32, 45). This has not been regarded as a major mechanism behind the induction of the primed response, most probably due to the findings in a paper published in 1984 by Guthrie et al. (19), which reported that LPS priming of the oxidative response was not accompanied by an increased number of cell surface FPR, at that time believed to be mobilized from a storage pool identified as the specific granules. However, since then, secretory vesicles and gelatinase granules, both of which store FPR (40), have been identified (7, 25). Based on our findings that LPS priming is accompanied by increased exposure of the FPR on the cell surface, we challenge the prevailing view and suggest that receptor upregulation from granule stores indeed makes an important contribution to the LPS-induced priming of the neutrophil response to fMLF. In fact, in cells incubated at 4 or 37°C, without or with LPS, the relative levels of fMLF cell surface binding (100, 130, and 280, respectively [Fig. 5]) agree very well with the relative levels of fMLF-induced activation (100, 160, and 280, respectively [Fig. 1]).
To further investigate the role of intracellular storage granules in LPS priming, we examined enucleated cytoplasts which lack such granules and have successfully been used for similar purposes (11, 15). The galectin-3-induced NADPH oxidase response present in nontreated cytoplasts was not enhanced by LPS, supporting a role for granule mobilization in the priming process. The presence of galectin-3 responsiveness in nonprimed cytoplasts is not surprising since it is well known that the cytoplast preparation procedure (involving an ultracentrifugation step at 37°C in the presence of the actin-disrupting drug cytochalasin B) results in some granule mobilization (36). It is difficult to evaluate the exact magnitude of the activation in cytoplasts (about 30% of an equivalent number of neutrophils) since plasma membrane is lost during cytoplast preparation (37).
Additional effects related to gelatinase granule mobilization may also
be important for the priming phenomenon. Proteases released from the
gelatinase granules have been proposed to be involved in remodeling of
the cell surface, resulting in shedding of interleukin-8 receptors,
Fc
RIII, L-selectin, and CR1 (5, 23, 33, 38). Such
proteolytic reorganization of the cell surface may result in increased
accessibility or activation of other receptors. Mobilization of
secretory vesicle or gelatinase granules also results in transfer of
the b cytochrome (a membrane component of the NADPH oxidase)
to the plasma membrane, which has been indicated to be a decisive
effect of LPS priming resulting in enhanced assembly of the NADPH
oxidase (13).
Galectin-3 differs from fMLF in that it did not activate nonprimed peripheral blood neutrophils (Fig. 2). It only slightly activated cells incubated at 37°C without LPS, whereas with LPS strong activation was seen. Hence, LPS converts the neutrophils from galectin-3 nonresponsive to galectin-3 responsive. This applies both to the extracellular (Fig. 2) and intracellular (Fig. 3) production of oxygen radicals.
A reasonable explanation for the LPS priming of neutrophils vis-à-vis activation by galectin-3 is the transfer of galectin-3 receptors to the plasma membrane when gelatinase granules are mobilized. Previously we have shown that CD66a and CD66b (CEACAM1 and CEACAM8, respectively [4]) are possible receptors for galectin-3 and reside in gelatinase granules of unprimed neutrophils (16, 22). However, as with fMLF, we cannot exclude that other rearrangements of the cell surface accompanying gelatinase granule mobilization are also involved in the induction of galectin-3 responsiveness. Since LPS treatment did not affect the NADPH oxidase response to the protein kinase C agonist PMA, we conclude that direct effects on the NADPH oxidase assembly or activity are not plausible explanations of the priming effect.
The difference between fMLF and galectin-3 regarding responsiveness or priming is probably dependent primarily on receptor localization. The fMLF receptors are localized not only in gelatinase granules but also on the cell surface in resting cells as well as in the easily mobilized secretory vesicles. In contrast, very few of the galectin-3 receptors (CD66a and CD66b) are present on the surface of resting cells or in secretory vesicles but reside mainly in the gelatinase and specific granules. Thus, the increased responsiveness to fMLF in cells incubated only at 37°C is probably due primarily to mobilization of fMLF receptors from secretory vesicles, while galectin-3 still cannot bind and activate the cells. However, after mobilization also of the gelatinase granules, the response to fMLF increases further, and the response to galectin-3 appears.
Although the gelatinase granule release in cells incubated at 37°C without LPS is around 20% there is only a slight (much less than 20%) galectin-3-induced response. Since galectin-3-induced activation of neutrophils is dependent on the N-terminal, aggregating domain of the molecule (22), a plausible explanation to the discrepancy is that the neutrophil surface has to expose a threshold amount of receptor molecules for an aggregation of galectin-3 to occur, thereby cross-linking receptors on the cell surface.
Infections involving gram-negative bacteria are accompanied by accumulation of LPS in the vicinity of the infection site. The involvement of inflammatory cells in this event is evident, and LPS induces the production of various inflammatory cytokines in monocytes and macrophages, enhancing the inflammatory process (34). The activation of monocytes/macrophages by LPS also leads to an increased production and release of galectin-3 (2, 28). The results we present here show that LPS in addition primes neutrophils to further activation by galectin-3. This suggests that galectin-3 may play an active role at the site of infection, exhibiting proinflammatory functions. Furthermore, the need for priming of the neutrophils to achieve a responding cell (e.g., to galectin-3) may per se be a regulatory mechanism, inducing a cellular response (such as release of toxic oxygen radicals) only at sites where it is functional and necessary, e.g., in inflamed or infected areas.
If released in sufficient amounts and systemically, LPS may cause the pathophysiological state known as bacterial sepsis or endotoxic shock, with subsequent failure of various organs. These frequently fatal syndromes appear to require neutrophil leukocytes. In cases of sepsis, LPS is probably the sole or major factor priming the neutrophils in the bloodstream. This results in a distinctive functional profile of the neutrophils in which they have decreased chemotactic responsiveness but increased adhesiveness and hypersensitivity to various activators of oxygen radical and protease release (46, 48). Many host factors, including tumor necrosis factor alpha and other cytokines, have been implicated as such activators and thus as important cofactors to LPS in propagating the neutrophil-induced tissue injury seen in septic shock and organ failure; antagonists of them have been tried therapeutically without much success (21). The present results suggest that neutrophils in this endotoxic state (46) have mobilized a major part of their gelatinase granules, and, moreover, have become hyperresponsive to galectin-3. This adds gelatinase granule contents, e.g., gelatinase, and galectin-3, to the host factors that might be important for development of septic shock and organ failure in conjunction with endotoxinemia.
| |
ACKNOWLEDGMENTS |
|---|
The skillful technical assistance of Lisbeth Björck and Marie Samuelsson is gratefully acknowledged.
This work was supported by the Fredrik and Ingrid Thuring Foundation, Swedish Rheumatism Association, Swedish Society for Medicine, Anna-Greta Crafoord Foundation for Rheumatological Research, Swedish Medical Research Council, and Swedish network and graduate school for inflammation research.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Phagocyte Research Laboratory, Department of Medical Microbiology and Immunology, Box 435, S-405 30 Göteborg, Sweden. Phone: 46-31-342 46 35. Fax: 46-31-82 88 98. E-mail: anna.karlsson{at}microbio.gu.se.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Andersson, T., C. Dahlgren, P. D. Lew, and O. Stendahl. 1987. Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate. J. Clin. Investig. 79:1226-1233. |
| 2. | Askew, D., A. D. Yurochko, C. J. Burger, and K. D. Elgert. 1990. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics. Immunol. Lett. 24:21-29[CrossRef][Medline]. |
| 3. |
Babior, B. M.
1999.
NADPH oxidase: an update.
Blood
93:1464-1476 |
| 4. | Beauchemin, N., P. Draber, G. Dveksler, P. Gold, S. Gray-Owen, F. Grunert, S. Hammarström, K. V. Holmes, A. Karlsson, M. Kuroki, S. H. Lin, L. Lucka, S. M. Najjar, M. Neumaier, B. Öbring, J. E. Shively, K. M. Skubitz, C. P. Stanners, P. Thomas, J. A. Thompson, M. Virji, S. vonKleist, C. Wagener, S. Watt, and W. Zimmermann. 1999. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res. 252:243-249[CrossRef][Medline]. |
| 5. | Bennett, T. A., E. B. Lynam, L. A. Sklar, and S. Rogelj. 1996. Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation. J. Immunol. 156:3093-3097[Abstract]. |
| 6. |
Borregaard, N., and J. B. Cowland.
1997.
Granules of the human neutrophilic polymorphonuclear leukocyte.
Blood
89:3503-3521 |
| 7. |
Borregaard, N.,
J. M. Heiple,
E. R. Simons, and R. A. Clark.
1983.
Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.
J. Cell Biol.
97:52-61 |
| 8. | Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Lab. Investig. 21:77-89. |
| 9. | Condliffe, A. M., E. Kitchen, and E. R. Chilvers. 1998. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin. Sci. (Colch) 94:461-471[Medline]. |
| 10. | Dahlgren, C., A. Johansson, H. Lundqvist, O. W. Bjerrum, and N. Borregaard. 1992. Activation of the oxygen-radical-generating system in granules of intact human neutrophils by a calcium ionophore (ionomycin). Biochim. Biophys. Acta 1137:182-188[Medline]. |
| 11. | Dahlgren, C., A. Johansson, and K. Orselius. 1989. Difference in hydrogen peroxide release between human neutrophils and neutrophil cytoplasts following calcium ionophore activation. A role of the subcellular granule in activation of the NADPH-oxidase in human neutrophils? Biochim. Biophys. Acta 1010:41-48[Medline]. |
| 12. | Dahlgren, C., and A. Karlsson. 1999. The neutrophil respiratory burst oxidase. J. Immunol. Methods 232:3-14[CrossRef][Medline]. |
| 13. | DeLeo, F. R., J. Renee, S. McCormick, M. Nakamura, M. Apicella, J. P. Weiss, and W. M. Nauseef. 1998. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J. Clin. Investig. 101:455-463[Medline]. |
| 14. | Downey, G. P., T. Fukushima, L. Fialkow, and T. K. Waddell. 1995. Intracellular signaling in neutrophil priming and activation. Semin. Cell Biol. 6:345-356[CrossRef][Medline]. |
| 15. |
English, D., and T. G. Gabig.
1986.
Differentiation of cellular processes involved in the induction and maintenance of stimulated neutrophil adherence.
Blood
67:1314-1322 |
| 16. |
Feuk-Lagerstedt, E.,
E. T. Jordan,
H. Leffler,
C. Dahlgren, and A. Karlsson.
1999.
Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils.
J. Immunol.
163:5592-5598 |
| 17. | Follin, P., G. Briheim, and C. Dahlgren. 1991. Mechanisms in neutrophil priming: characterization of the oxidative response induced by formylmethionyl-leucyl-phenylalanine in human exudated cells. Scand. J. Immunol. 34:317-322[CrossRef][Medline]. |
| 18. | Gottlieb, C., K. Lau, L. R. Wasserman, and V. Herbert. 1965. Rapid charcoal assay for intrinsic factor (IF), gastric juice unsaturated B12 binding capacity, antibody to IF, and serum unsaturated B12 binding capacity. J. Hematol. 25:875-883. |
| 19. |
Guthrie, L. A.,
L. C. McPhail,
P. M. Henson, and R. B. Johnston, Jr.
1984.
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharides.
J. Exp. Med.
160:1656-1671 |
| 20. | Hallett, M. B., and D. Lloyds. 1995. Neutrophil priming: the cellular signals that say `amber' but not `green'. Immunol. Today 16:264-268[CrossRef][Medline]. |
| 21. | Karima, R., S. Matsumoto, H. Higashi, and K. Matsushima. 1999. The molecular pathogenesis of endotoxic shock and organ failure. Mol. Med. Today 5:123-132[CrossRef][Medline]. |
| 22. |
Karlsson, A.,
P. Follin,
H. Leffler, and C. Dahlgren.
1998.
Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils.
Blood
91:3430-3438 |
| 23. |
Khandaker, M. H.,
G. Mitchell,
L. Xu,
J. D. Andrews,
R. Singh,
H. Leung,
J. Madrenas,
S. S. Ferguson,
R. D. Feldman, and D. J. Kelvin.
1999.
Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.
Blood
93:2173-2185 |
| 24. | Kjeldsen, L., O. W. Bjerrum, D. Hovgaard, A. H. Johnsen, M. Sehested, and N. Borregaard. 1992. Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. Eur. J. Haematol. 49:180-191[Medline]. |
| 25. |
Kjeldsen, L.,
H. Sengeløv,
K. Lollike,
M. H. Nielsen, and N. Borregaard.
1994.
Isolation and characterization of gelatinase granules from human neutrophils.
Blood
83:1640-1649 |
| 26. | Leffler, H. 1997. Introduction to galectins. Trends Glycosci. Glycotechnol. 9:9-19. |
| 27. |
Lindstedt, R.,
G. Apodaca,
S. H. Barondes,
K. E. Mostov, and H. Leffler.
1993.
Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway.
J. Biol. Chem.
268:11750-11757 |
| 28. | Liu, F. T., D. K. Hsu, R. I. Zuberi, I. Kuwabara, E. Y. Chi, and W. R. Henderson, Jr. 1995. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147:1016-1028[Abstract]. |
| 29. | Lundahl, J., C. Dahlgren, A. Eklund, J. Hed, R. Hernbrand, and G. Tornling. 1993. Quartz selectively down-regulates CR1 on activated human granulocytes. J. Leukoc. Biol. 53:99-103[Abstract]. |
| 30. | Lundqvist, H., and C. Dahlgren. 1996. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radical Biol. Med. 20:785-792[CrossRef][Medline]. |
| 31. | Massa, S. M., D. N. Cooper, H. Leffler, and S. H. Barondes. 1993. L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry 32:260-267[CrossRef][Medline]. |
| 32. | McLeish, K. R., J. B. Klein, E. D. Lederer, K. Z. Head, and R. A. Ward. 1996. Azothemia, TNF alpha, and LPS prime the neutrophil oxidative burst by distinct mechanisms. Kidney Int. 50:407-416[Medline]. |
| 33. |
Middelhoven, P. J.,
A. Ager,
D. Roos, and A. J. Verhoeven.
1997.
Involvement of a metalloprotease in the shedding of human neutrophil Fc RIIIB.
FEBS Lett.
414:14-18[CrossRef][Medline].
|
| 34. | Murphy, K., S. B. Haudek, M. Thompson, and B. P. Giroir. 1998. Molecular biology of septic shock. New Horiz. 6:181-193[Medline]. |
| 35. | Nathan, C. F. 1987. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Investig. 80:1550-1560. |
| 36. |
Petrequin, P. R.,
R. F. Todd III,
J. E. Smolen, and L. A. Boxer.
1986.
Expression of specific granule markers on the cell surface of neutrophil cytoplasts.
Blood
67:1119-1125 |
| 37. |
Roos, D.,
A. A. Voetman, and L. J. Meerhof.
1983.
Functional activity of enucleated human polymorphonuclear leukocytes.
J. Cell Biol.
97:368-377 |
| 38. | Sadallah, S., C. Hess, S. Miot, O. Spertini, H. Lutz, and J. A. Schifferli. 1999. Elastase and metalloproteinase activities regulate soluble complement receptor 1 release. Eur. J. Immunol. 29:3754-3761[CrossRef][Medline]. |
| 39. |
Sato, S., and R. C. Hughes.
1994.
Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages.
J. Biol. Chem.
269:4424-4430 |
| 40. | Sengeløv, H., F. Boulay, L. Kjeldsen, and N. Borregaard. 1994. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem. J. 299:473-479. |
| 41. |
Sengeløv, H.,
L. Kjeldsen,
M. S. Diamond,
T. A. Springer, and N. Borregaard.
1993.
Subcellular localization and dynamics of Mac-1 ( m 2) in human neutrophils.
J. Clin. Investig.
92:1467-1476.
|
| 42. | Sengeløv, H., L. Kjeldsen, W. Kroeze, M. Berger, and N. Borregaard. 1994. Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils. J. Immunol. 153:804-810[Abstract]. |
| 43. |
Surette, M. E.,
N. Dallaire,
N. Jean,
S. Picard, and P. Borgeat.
1998.
Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils.
FASEB J.
12:1521-1531 |
| 44. | Tauber, A. I., A. B. Karnad, K. L. Hartshorn, J. B. Myers, and J. H. Schwartz. 1989. Biochemistry of the acute allergic reactions: 5th International Symposium, p. 297-309. Alan R. Liss, Inc., New York, N.Y. |
| 45. | Vosbeck, K., P. Tobias, H. Mueller, R. A. Allen, K. E. Arfors, R. J. Ulevitch, and L. A. Sklar. 1990. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J. Leukoc. Biol. 47:97-104[Abstract]. |
| 46. | Wagner, J. G., and R. A. Roth. 1999. Neutrophil migration during endotoxemia. J. Leukoc. Biol. 66:10-24[Abstract]. |
| 47. | Watson, F., and S. W. Edwards. 1998. Stimulation of primed neutrophils by soluble immune complexes: priming leads to enhanced intracellular Ca2+ elevations, activation of phospholipase D, and activation of the NADPH oxidase. Biochem. Biophys. Res. Commun. 29:819-826. |
| 48. | Welbourn, C. R., and Y. Young. 1992. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br. J. Surg. 79:998-1003[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|